Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Loren D. Grossman"'
Publikováno v:
Frontiers in Psychology, Vol 9 (2018)
Performing and creative artists have unique occupational and lifestyle stresses and challenges that can negatively affect self-esteem. Low self-esteem not only has serious implications for their psychological and physical health, it can also affect t
Externí odkaz:
https://doaj.org/article/0922eb9777ad414f879a0ccd8e81389d
Publikováno v:
Canadian Journal of Diabetes. 42:S154-S161
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3711768a7bafbb399dfec77fde0dfd11
https://doi.org/10.1016/j.jcjd.2017.10.023
https://doi.org/10.1016/j.jcjd.2017.10.023
Publikováno v:
Clinical Therapeutics. 31:74-88
Objective: Pioglitazone (PIO), a thiazolidinedione (TZD), is reported to be highly effective in the treatment of type 2 diabetes mellitus, but is associated with edema, heart failure, and weight gain. This study documented long-term tolerability outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c572e9fffeee6e788b434a150d52494
https://doi.org/10.1016/j.clinthera.2009.01.004
https://doi.org/10.1016/j.clinthera.2009.01.004
Autor:
Vinod Mattoo, David Eckland, Debbie Knight, Carmen Fajardo, M. H. Tan, Mario Widel, Jorma Strand, Loren D. Grossman, Santiago Duran, David Oakley
Publikováno v:
Clinical Therapeutics. 27:554-567
Type 2 diabetes mellitus (DM) is a progressive disease. Initial therapy begins with dietary and lifestyle modifications. However, as the disease progresses, glycemic control becomes more difficult to attain, often requiringor =1 oral antihyperglycemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c1a3147e3591a4906ecf5c14e68e485
https://doi.org/10.1016/j.clinthera.2005.05.005
https://doi.org/10.1016/j.clinthera.2005.05.005
Autor:
Loren D. Grossman
Publikováno v:
PharmacoEconomics. 20:1-9
Type 2 diabetes mellitus remains a significant burden to the Canadian healthcare system. Over 2 million Canadians have diabetes, with 85 to 90% having type 2 diabetes. Insulin resistance is a major pathophysiological mechanism in the development of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bda434cdfa33ab69461f38a8cfca2477
https://doi.org/10.2165/00019053-200220001-00001
https://doi.org/10.2165/00019053-200220001-00001
Publikováno v:
PharmacoEconomics. 18:275-287
Objective:To measure the economic value of a new insulin formulation consisting of rapid-acting insulin lispro and intermediate-acting neutral protamine lispro in a 25: 75 ratio (Humalog® Mix 25™). Design and Setting: A cost-benefit analysis using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3976093b96f4d5dd70a38e43d2f74612
https://doi.org/10.2165/00019053-200018030-00007
https://doi.org/10.2165/00019053-200018030-00007
Autor:
Loren D. Grossman
Publikováno v:
Journal SOGC. 22:183-190
women can now expect to live up to one-third of their lives in the post-menopausal state. This low estrogen state is a major risk factor for the development of osteoporosis and cardiovascular disease. The Osteoporosis Society of Canada currently reco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8448d07129e4ab5d196a21fedd1e4edb
https://doi.org/10.1016/s0849-5831(16)31475-6
https://doi.org/10.1016/s0849-5831(16)31475-6
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research. 4(2)
Diabetes remains a significant economic burden to national healthcare systems. The traditional oral agents used to treat Type 2 diabetes do not address the underlying insulin resistance responsible for the development of diabetes. Newer medications,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92e7a66f53d87f37f85d5d1bd89c8f4d
https://pubmed.ncbi.nlm.nih.gov/19807516
https://pubmed.ncbi.nlm.nih.gov/19807516
Autor:
Christopher S Konkoy, Loren D. Grossman, Santiago Duran, Jesús Reviriego, Don Johns, Chantal Godin, Heather Lochnan, Matthias Herz, Philip A Hardin, Federico Hawkins, Fernando Escobar-Jiménez, Meng H. Tan
Publikováno v:
Clinical therapeutics. 25(4)
The goal of this study was to compare the effects of 2 doses of pioglitazone hydrochloride (a thiazolidinedione insulin sensitizer) with placebo on glycated hemoglobin (HbA(1c)), insulin sensitivity, and lipid profiles in patients with type 2 diabete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fc12288c1f111176abf49953431379f
https://pubmed.ncbi.nlm.nih.gov/12809958
https://pubmed.ncbi.nlm.nih.gov/12809958